Lucieli Ceolin

740 total citations
19 papers, 419 citations indexed

About

Lucieli Ceolin is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Lucieli Ceolin has authored 19 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Lucieli Ceolin's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cancer-related Molecular Pathways (5 papers). Lucieli Ceolin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cancer-related Molecular Pathways (5 papers). Lucieli Ceolin collaborates with scholars based in Brazil, Belgium and Italy. Lucieli Ceolin's co-authors include Ana Luiza Maia, Carla Vaz Ferreira, Mírian Romitti, Débora Rodrigues Siqueira, Simone Magagnin Wajner, Márcia Puñales, José Miguel Dora, Edna Teruko Kimura, Torsten Reese and Léa Maria Zanini Maciel and has published in prestigious journals such as PLoS ONE, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Lucieli Ceolin

19 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucieli Ceolin Brazil 13 297 120 99 81 73 19 419
Susan C. Lindsey Brazil 12 253 0.9× 125 1.0× 66 0.7× 82 1.0× 62 0.8× 28 399
Hanna Pisarek Poland 12 291 1.0× 99 0.8× 69 0.7× 172 2.1× 46 0.6× 51 468
Laís Moraes Brazil 9 207 0.7× 94 0.8× 63 0.6× 27 0.3× 83 1.1× 14 308
Peter Groth Germany 10 335 1.1× 126 1.1× 93 0.9× 117 1.4× 66 0.9× 18 479
Daniela Cordella Italy 8 183 0.6× 178 1.5× 64 0.6× 38 0.5× 54 0.7× 9 367
S Khalaf United Kingdom 8 135 0.5× 135 1.1× 74 0.7× 76 0.9× 23 0.3× 13 415
Marco Martinelli Italy 7 202 0.7× 126 1.1× 104 1.1× 25 0.3× 46 0.6× 12 354
C Houdent France 6 211 0.7× 102 0.8× 73 0.7× 109 1.3× 56 0.8× 25 330
José Mario González-Meljem United Kingdom 10 146 0.5× 224 1.9× 44 0.4× 53 0.7× 21 0.3× 17 477

Countries citing papers authored by Lucieli Ceolin

Since Specialization
Citations

This map shows the geographic impact of Lucieli Ceolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucieli Ceolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucieli Ceolin more than expected).

Fields of papers citing papers by Lucieli Ceolin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucieli Ceolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucieli Ceolin. The network helps show where Lucieli Ceolin may publish in the future.

Co-authorship network of co-authors of Lucieli Ceolin

This figure shows the co-authorship network connecting the top 25 collaborators of Lucieli Ceolin. A scholar is included among the top collaborators of Lucieli Ceolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucieli Ceolin. Lucieli Ceolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schiavo, Andréa Alex, Bárbara F. Fonseca, Lucieli Ceolin, et al.. (2023). Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids. Oncogene. 43(3). 155–170. 19 indexed citations
2.
Ceolin, Lucieli, Iuri Martin Goemann, Roberta Rigo Dalla Corte, et al.. (2022). Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study. Metabolites. 12(5). 375–375. 1 indexed citations
3.
Scheffel, Rafael Selbach, Mírian Romitti, Lucieli Ceolin, et al.. (2020). The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma. Archives of Endocrinology and Metabolism. 64(6). 751–757. 15 indexed citations
4.
Ceolin, Lucieli, et al.. (2020). The tissue expression pattern of CA 19.9 is associated with oncological features in medullary thyroid carcinoma. Endocrine. 70(3). 544–551. 4 indexed citations
5.
Ceolin, Lucieli, et al.. (2019). Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocrine Related Cancer. 26(9). R499–R518. 95 indexed citations
6.
Ceolin, Lucieli, et al.. (2018). Global DNA methylation profile in medullary thyroid cancer patients. Experimental and Molecular Pathology. 105(1). 110–114. 16 indexed citations
7.
Romitti, Mírian, Simone Magagnin Wajner, Lucieli Ceolin, et al.. (2016). MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocrine Related Cancer. 23(3). 135–146. 33 indexed citations
8.
9.
Ceolin, Lucieli, Mírian Romitti, Débora Rodrigues Siqueira, et al.. (2016). Effect of 3′UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma. PLoS ONE. 11(2). e0147840–e0147840. 6 indexed citations
10.
Siqueira, Débora Rodrigues, Lucieli Ceolin, Carla Vaz Ferreira, et al.. (2014). Role of RET genetic variants in MEN2-associated pheochromocytoma. European Journal of Endocrinology. 170(6). 821–828. 24 indexed citations
11.
Ferreira, Carla Vaz, Débora Rodrigues Siqueira, Mírian Romitti, et al.. (2014). Role of VEGF-A and Its Receptors in Sporadic and MEN2-Associated Pheochromocytoma. International Journal of Molecular Sciences. 15(4). 5323–5336. 10 indexed citations
12.
Maia, Ana Luiza, et al.. (2013). Advanced medullary thyroid cancer: pathophysiology and management. Cancer Management and Research. 5. 57–57. 19 indexed citations
13.
Ceolin, Lucieli, et al.. (2012). Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness. European Journal of Endocrinology. 166(5). 847–854. 25 indexed citations
14.
Ceolin, Lucieli, et al.. (2012). The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature. Arquivos Brasileiros de Endocrinologia & Metabologia. 56(8). 586–591. 3 indexed citations
15.
Romitti, Mírian, Lucieli Ceolin, Débora Rodrigues Siqueira, et al.. (2012). Signaling pathways in follicular cell-derived thyroid carcinomas. International Journal of Oncology. 42(1). 19–28. 34 indexed citations
16.
Weinert, Letícia Schwerz, Lucieli Ceolin, Mírian Romitti, Eduardo Guimarães Camargo, & Ana Luiza Maia. (2012). Is there a role for inherited TR βmutation in human carcinogenesis?. Arquivos Brasileiros de Endocrinologia & Metabologia. 56(1). 67–71. 9 indexed citations
17.
Ceolin, Lucieli, Débora Rodrigues Siqueira, Mírian Romitti, Carla Vaz Ferreira, & Ana Luiza Maia. (2011). Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms. International Journal of Molecular Sciences. 13(1). 221–239. 32 indexed citations
18.
Siqueira, Débora Rodrigues, et al.. (2010). The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma. Endocrine Related Cancer. 17(4). 953–963. 32 indexed citations
19.
Gozzi, Alessandro, et al.. (2006). A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan C. Lindsey Breakdown of academic impact, for papers by Hanna Pisarek Breakdown of academic impact, for papers by Laís Moraes Breakdown of academic impact, for papers by Peter Groth Breakdown of academic impact, for papers by Daniela Cordella Breakdown of academic impact, for papers by S Khalaf Breakdown of academic impact, for papers by Marco Martinelli Breakdown of academic impact, for papers by C Houdent Breakdown of academic impact, for papers by José Mario González-Meljem
Rankless by CCL
2026